September 27, 2024 by University College London Lamotrigine, a drug commonly used to treat epilepsy and certain mood disorders, has been shown to be an excellent treatment option for a rare genetic neuromuscular disease known as non-dystrophic myotonia, in a world-first trial led by University College London researchers. The study, published in The Lancet Neurology,...